I like the risk reward. Nothing guaranteed but at the current market cap, if the trial shows promise, given its an oral drug, the stock price could explode. I believe big pharma is closely watching the results of the trial. There is a lot of buzz. I believe they will partner if data is good. Av-101 may be used for multiple indications.
News 
Market Data 
Discover 
